StockWatch
·

Tracxn Technologies Ltd

BSE: 543638

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
22.68
+0.4%+0.8%
Expenditure
27.32
+7.7%+25.0%
Net Profit
-4.13
-37.1%+25.8%
OPM %
-27.92%
-7.84pp-25.21pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-11.77-0.959.8720.6931.51Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Flat revenue masks an unproven playbook — and an institution in retreat

earnings review · growth inflection · international expansion

Result verdictFollow-upQ2 FY2705 Nov 20266 minTechnology / IT

Flat revenue masks heavy pre-profitability investment; playbook unproven at scale

India acceleration · three-phase playbook · sales expansion

TranscriptDeep diveQ2 FY2705 Nov 20266 minTechnology / IT

Tracxn Q2 FY27: revenue near-flat, operating margin craters to -28% as staff costs surge

saas · flat revenue · margin compression

ResultsQ2 FY2704 Nov 20263 minTechnology / IT
Latest
Board Meeting4 Nov, 3:48 pm

Tracxn Q2 FY27: revenue near-flat, operating margin craters to -28% as staff costs surge

Tracxn's standalone revenue from operations came in at ₹21.30 Cr, up just 0.26% YoY and 1.06% QoQ — effectively flat against management's own FY27 guidance of 15-20% India growth given on the Q1 call. The company swung to an operating loss of ₹5.95 Cr (OPM -27.9%) from an operating margin of -2.7% a year ago and -20.1% last quarter, as employee benefit expense rose 22.5% YoY (₹19.04 Cr → ₹23.33 Cr) and 6.1% QoQ (₹21.98 Cr → ₹23.33 Cr) — well ahead of the ~10% annualized expense growth management had guided to. Net loss for the quarter was ₹4.13 Cr, widening 37% from ₹3.01 Cr in Q1 FY27. On a YoY basis the headline loss looks smaller (₹4.13 Cr vs ₹5.56 Cr, -26% narrower), but that comparison is distorted: Q2 FY26 carried a one-off-looking ₹6.19 Cr tax charge against a near-breakeven ₹0.62 Cr pretax profit, while this quarter booked a small ₹0.52 Cr tax credit. The H1 FY27 loss of ₹7.14 Cr versus ₹4.44 Cr in H1 FY26 (a 61% YoY widening) is the more reliable comparison and confirms profitability deteriorated, not improved. No formal street estimates could be located for this print — Tracxn is a small-cap (equity base ~₹10.70 Cr paid-up) with thin analyst coverage and no identifiable published Q2 FY27 preview, so vsStreet is marked unknown rather than guessed. Against the company's own prior guidance the quarter missed on both counts that matter: India growth was expected at the higher end of 15-20% for FY27, but standalone revenue barely moved, and expense growth of ~10% annualized was the stated ceiling while employee costs alone grew more than double that pace YoY. No company press release accompanying this filing was available to cross-check management's own framing of the quarter. The margin squeeze sits almost entirely on the employee benefits line — ESOP expense was a trivial ₹0.58 Cr (versus ₹0.576 Cr in Q1), so the increase is driven by cash employee costs (hiring/wage growth), not stock compensation. Other expenses also rose, up 17.7% QoQ (₹3.33 Cr → ₹3.92 Cr) and 41% YoY. On the developments side, the company closed its trading window ahead of results (Sep 25), granted 135,404 ESOPs (Aug 27), and — most relevant to the revenue story — launched an 'AI Suite for Company Research' on October 15, 2026, part of the AI-product push management said in the Q1 call would start contributing revenue in FY27; that contribution is not yet visible in a topline growing well under 1% YoY. Going into Q3, the quarter sets up a clear tension: management's FY27 growth and cost-discipline guidance versus two consecutive quarters of flat revenue and expense growth running at more than double the guided rate. The AI Suite is too recent to have shown up in this print.

4 Nov 2026, 03:48 pm

Board Meeting5 Aug, 3:45 pm

Tracxn swings to ₹3.01 Cr Q1 FY27 loss as staff costs outpace flat revenue

Tracxn Technologies' standalone (and only, since it has no subsidiaries) results for the quarter ended June 30, 2026 show a swing to a net loss of ₹3.01 Cr, reversing the ₹1.12 Cr profit reported a year ago, even as revenue from operations was roughly flat at ₹21.08 Cr (-0.6% YoY, +2.9% QoQ). This is a clear miss against management's own May 2026 guidance of "continued acceleration in India growth" from new data-set launches and expanded sales teams, plus an anticipated international rebound "from Q1 FY27 onwards" — neither shows up in the topline, and the company's single reportable-segment disclosure (Platform Subscription) means India/international performance can't be independently verified from this filing. No brokerage consensus estimate for this print could be confirmed via search, so vsStreet is marked unknown rather than assumed. The loss was driven almost entirely by cost growth: employee benefit expense, the dominant cost line, rose 16.0% YoY to ₹21.98 Cr while revenue stayed flat, pulling net margin from +5.3% to -14.3% YoY and operating margin from -1.1% to -20.3% YoY. Sequentially the picture didn't improve either — the loss widened 14.3% QoQ (₹2.63 Cr to ₹3.01 Cr) despite revenue growing 2.9% QoQ, so margin compression continued even with a stronger topline. There were no exceptional items this quarter, unlike Q4 FY26's ₹36.23 Lakh Labour Code charge, so the YoY comparison is clean and not flattered by one-offs either side. The results were approved a day after the company filed a corrigendum to its FY26 annual report (Aug 4) and follow a 261,617-option ESOP grant in late May — routine corporate items, not signals tied to the print. Going into Q2 FY27, the open question is whether the guided India acceleration and international rebound actually show up, since this quarter's flat revenue and 16% cost growth run counter to that narrative.

5 Aug 2026, 03:45 pm

Corporate Events

Board MeetingTRACXN
2026
4Nov

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingTRACXN
2026
27Aug

Board Meeting

The Nomination and Remuneration Committee approved the grant…

BSE Filing ↗
Board MeetingTRACXN
2026
17Aug

Board Meeting

The 14th Annual General Meeting (AGM) will be held to transa…

BSE Filing ↗
Board MeetingTRACXN
2026
5Aug

Board Meeting

A meeting of the Board of Directors of the Company is schedu…

BSE Filing ↗
Board MeetingTRACXN
2026
25May

Board Meeting

The board meeting is scheduled to consider and approve the A…

BSE Filing ↗
Board MeetingTRACXN
2025
26May

Board Meeting

Audited Financial Results, Buyback of fully paid-up equity s…

BSE Filing ↗
Board MeetingTRACXN
2024
8Nov

Board Meeting

Update on board meeting, Consider, approve and take on recor…

BSE Filing ↗
Board MeetingTRACXN
2024
31Jul

Board Meeting

Consider and approve Un-Audited Financial Results, consider …

BSE Filing ↗
Board MeetingTRACXN
2024
20May

Board Meeting

Consider and approve Audited Financial Results

BSE Filing ↗
Board MeetingTRACXN
2024
31Jan

Board Meeting

consider and approve Un-Audited Financial Results for the qu…

BSE Filing ↗
Board MeetingTRACXN
2023
2Nov

Board Meeting

Approval of Un-Audited Financial Results for the quarter and…

BSE Filing ↗